Publications

Search our bibliography using the filters on the right-hand side.

Displaying 51 through 100 of 350 publications.

Nillni YI, Wesselink AK, Gradus JL, Hatch EE, Rothman KJ, Mikkelsen EM, Wise LA. Depression, anxiety, and psychotropic medication use and fecundability. Am J Obstet Gynecol. 2016 Oct;215(4):453.e1-8. doi: 10.1016/j.ajog.2016.04.022

Vilor-Tejedor N, Alemany S, Forns J, Caceres A, Murcia M, Macia D, Pujol J, Sunyer J, Gonzalez JR. Assessment of susceptibility risk factors for ADHD in imaging genetic studies. J Atten Disord. 2016 Aug 17.

Farreny A, Aguado J, Corbera S, Ochoa S, Huerta-Ramos E, Usall J. Baseline predictors for success following strategy-based cognitive remediation group training in schizophrenia. J Nerv Ment Dis. 2016 Aug;204(8):585-9. doi: 10.1097/NMD.0000000000000509

DiBenedetti DB, Brown TM, Danchenko N. Assessing patient and caregiver experiences with symptoms and behaviors associated with schizophrenia. J Depress Anxiety. 2016 Jul 17;5(3):240. doi: 10.4200/2167-1044.1000240

Quteineh L, Preisig M, Rivera M, Milaneschi Y, Castelao E, Gholam-Rezaee M, Vandenberghe F, Saigi-Morgui N, Delacretaz A, Cardinaux JR, Willemsen G, Boomsma DI, Penninx BW, Ching-Lopez A, Conus P, Eap CB. Association of CRTC1 polymorphisms with obesity markers in subjects from the general population with lifetime depression. J Affect Disord. 2016 Jul;198:43-9. doi: 10.1016/j.jad.2016.03.031

Brown TM, DiBenedetti DB, Danchenko N, Weiller E, Fava M. Symptoms of anxiety and irritability in patients with major depressive disorder. J Depress Anxiety. 2016 Jun 18;5:237. doi: 10.4200/2167-1044.1000237

Herman BK, Deal LS, DiBenedetti DB, Nelson L, Fehnel SE, Brown TM. Development of the 7-Item Binge Eating Disorder Screener (BEDS-7). Prim Care Companion CNS Disord. 2016 Jun;18(2). doi: 10.4088/PCC.15m01896

Luquiens A, Whalley D, Laramee P, Falissard B, Kostogianni N, Rehm J, Manthey J, Paille F, Aubin HJ. Validation of a new patient-reported outcome instrument of health-related quality of life specific to patients with alcohol use disorder: the Alcohol Quality of Life Scale (AQoLS). Qual Life Res. 2016 Jun;25(6):1549-60. doi: 10.1007/s11136-015-1190-5

Herman BK, Deal LS, DiBenedetti DB, Nelson L, Fehnel SE, Brown TM. The use and value of the seven-item binge eating disorder screener in clinical practice. Poster presented at the American Psychiatric Association Annual Meeting; May 17, 2016. Atlanta, GA.

Muser E, Benson C, Chirila C, Graham J, Woodruff K. Resource use and cost in a randomized, non-inferiority trial of paliperidone palmitate 3 versus 1-month formulations in patients with schizophrenia. Poster presented at the 2016 American Psychiatric Association Annual Meeting; May 14, 2016. Atlanta, GA.

Saigi-Morgui N, Vandenberghe F, Delacretaz A, Quteineh L, Gholamrezaee M, Aubry JM, von Gunten A, Kutalik Z, Conus P, Eap CB. Association of genetic risk scores with body mass index in Swiss psychiatric cohorts. Pharmacogenet Genomics. 2016 May;26(5):208-17. doi: 10.1097/FPC.0000000000000210

Dadvand P, Bartoll X, Basagana X, Dalmau-Bueno A, Martinez D, Ambros A, Cirach M, Triguero-Mas M, Gascon M, Borrell C, Nieuwenhuijsen MJ. Green spaces and general health: roles of mental health status, social support, and physical activity. Environ Int. 2016 May;91:161-7. doi: 10.1016/j.envint.2016.02.029

Novick D, Montgomery W, Aguado J, Peng XM, Haro JM. Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients. Neuropsychiatr Dis Treat. 2016 Apr 11;12:795-800. doi: 10.2147/NDT.S90134

Williams V, Francois C, Danchenko N, Nelson L, Williams N, Yarr S, DiBenedetti D, Lancon C. Psychometric validation of the depression and family functioning scale. Curr Med Res Opin. 2016 Apr;32(4):639-50. doi: 10.1185/03007995.2015.1135111

Naber D, Beillat M, DiBenedetti DB, Brown TM. Assessing the relevance of the Quality of Life Scale in schizophrenia: patient and caregiver perspectives. Poster presented at the 5th Biennial Schizophrenia International Research Society Conference; April 2016. Florence, Italy.

Woodruff K, Chirila C, Zheng Q, Van Impe K, Nuamah I. Healthcare resource use of paliperidone palmitate 3-month injection vs. paliperidone palmitate 1-month injection: an analysis of phase III clinical trial hospital data. Poster presented at the 24th European Congress of Psychiatry; March 15, 2016. Madrid, Spain.

Wilson MR, Gutierrez B, Offord S, Blanchette CM, Eramo A, Earnshaw SR, Kamat SA. Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia. Drugs Context. 2016 Mar 11;5:212273. doi: 10.7573/dic.212273

Fehnel SE, Forsyth BH, DiBenedetti DB, Danchenko N, Francios C, Brevig T. Patient-centered assessment of cognitive symptoms of depression. CNS Spectr. 2016 Feb;21(1):43-52. doi: 10.1017/S1092852913000643

Brodtkorb TH, Bell M, Irving AH, Laramee P. The cost effectiveness of nalmefene for reduction of alcohol consumption in alcohol-dependent patients with high or very high drinking-risk levels from a UK societal perspective. CNS Drugs. 2016 Feb;30(2):163-77. doi: 10.1007/s40263-016-0310-2

Marcano-Belisario JS, Gupta AK, O'Donoghue J, Morrison C, Car J. Tablet computers for implementing NICE antenatal mental health guidelines: protocol of a feasibility study. BMJ Open. 2016 Jan 22;6(1):e009930. doi: 10.1136/bmjopen-2015-009930

Novick D, Montgomery WS, Aguado J, Peng X, Brugnoli R, Haro JM. Which somatic symptoms are associated with an unfavorable course in Chinese patients with major depressive disorder? Asia Pac Psychiatry. 2015 Dec;7(4):427-35. doi: 10.1111/appy.12189

Vandenberghe F, Gholam-Rezaee M, Saigi-Morgui N, Delacretaz A, Choong E, Solida-Tozzi A, Kolly S, Thonney J, Gallo SF, Hedjal A, Ambresin AE, von Gunten A, Conus P, Eap CB. Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment. J Clin Psychiatry. 2015 Nov;76(11):e1417-23. doi: 10.4088/JCP.14m09358.

Delacretaz A, Preisiq M, Vandenberghe F, Saigi Morgui N, Quteineh L, Choong E, Gholam-Rezaee M, Kutalik Z, Magistretti P, Aubry JM, von Gunten A, Castelao E, Vollenweider P, Waeber G, Conus P, Eap CB. Influence of MCHR2 and MCHR2-AS1 genetic polymorphisms on body mass index in psychiatric patients and in population-based subjects with present or past atypical depression. PLoS One. 2015 Oct 13;10(10):e0139155. doi: 10.1371/journal.pone.0139155

Saigi-Morgui N, Vandenberghe F, Delacretaz A, Quteineh L, Choong E, Gholamrezaee M, Magistretti P, Aubry JM, von Gunten A, Preisig M, Castelao E, Vollenweider P, Waeber G, Kutalik Z, Conus P, Eap CB. Association of PCK1 with body mass index and other metabolic features in patients with psychotropic treatments. J Clin Psychopharmacol. 2015 Oct;35(5):544-52. doi: 10.1097/JCP.0000000000000388

Meyers J, Grebla R, Ajmera M, Davis K, Pawaskar M. Comorbidity burden in delayed and nondelayed ADHD diagnosis among commercially insured adults in the United States. Poster presented at the 28th Annual US Psychiatric and Mental Health Congress; September 10, 2015. San Diego, CA.

Hartry A, Francois C, Llorca PM, Lancon C, DiBenedetti D, Brown TM. Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications (AAP) in schizophrenia: the patient perspective. Poster presented at the 2015 US Psychiatric and Mental Health Congress (Psych Congress); September 10, 2015. San Diego, CA.

Hartry A, Francois C, Llorca PM, Lancon C, DiBenedetti D, Brown TM. Assessing the burden of treatment-emergent adverse events associated with Atypical Antipsychotic medications (AAPs) in Major Depressive Disorder (MDD): the patient perspective. Poster presented at the 2015 US Psychiatric and Mental Health Congress; September 2015. San Diego, CA.

Novick D, Montgomery W, Treuer T, Aguado J, Kraemer S, Haro JM. Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study. BMC Psychiatry. 2015 Aug 5;15:189. doi: 10.1186/s12888-015-0560-4.

Delacretaz A, Preisig M, Vandenberghe F, Saigi-Morgui N, Quteineh L, Choong E, Gholamrezaee M, Kutalik Z, von Gunten A, Castelao E, Vollenweider P, Conus P, Eap C. Influence of MCHR2 and MCHR2-AS1 genetic polymorphisms on body mass index in psychiatric patients and in subjects from the general population with present or past atypical depression. Presented at the 2015 World Congress of Biological Psychiatry; June 18, 2015. Athens, Greece.

Vandenberghe F, Saigi-Morgui N, Quteineh L, Gholamrezaee M, von Gunten A, Conus P, Eap CB. Clinical and genetic markers to predict a rapid and strong weight gain during psychotropic treatment. Presented at the 2015 World Congress of Biological Psychiatry; June 18, 2015. Athens, Greece.

Saigi-Morgui N, Vandenberghe F, Delacretaz A, Quteineh L, Gholamrezaee M, Kutalik Z, Aubry JM, von Gunten A, Conus P, Eap C. Influence of weighted genetic risk score on BMI in Swiss psychiatric cohorts. Presented at the 2015 World Congress of Biological Psychiatry; June 14, 2015. Athens, Greece.

Quteineh L, Vandenberghe F, Saigi-Morgui N, Delacretaz A, Choong E, Gholamrezaee M, von Gunten A, Preisig M, Castelao E, Vollenweider P, Kutalik Z, Conus P, Eap C. Impact of HSD11B1 polymorphisms on body mass index and components of the metabolic syndrome in patients with psychotropic treatments. Presented at the 2015 World Congress of Biological Psychiatry; June 2015. Athens, Greece.

Vandenberghe F, Saigi-Morgui N, Delacretaz A, Quteineh L, von Gunten A, Conus P, Eap CB. Genetic and clinical determinants of weight gain and/or metabolic syndrome in a large psychiatric sample treated with psychotropic drugs. Presented at the American Psychiatric Association 168th Annual Meeting; May 19, 2015. Toronto, Canada.

Herman BK, Deal LS, DiBenedetti DB, Nelson LM, Fehnel SE, Brown TM. Development of the binge eating disorder screener. Poster presented at the 168th American Psychiatric Association Annual Meeting; May 16, 2015. Toronto, Canada.

Quteineh L, Vandenberghe F, Saigi Morgui N, Delacretaz A, Choong E, Gholam-Rezaee M, Magistretti P, Bondolfi G, von Gunten A, Preisig M, Castelao E, Vollenweider P, Waeber G, Bochud M, Kutalik Z, Conus P, Eap CB. Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments. Pharmacogenet Genomics. 2015 May;25(5):246-58. doi: 10.1097/FPC.0000000000000131

Francois C, Danchenko N, Williams V, Nelson L, Williams NJ, Yarr S, DiBenedetti DB, Lancon C. Validation of the depression and family functioning scale (DFFS). Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015 May; 18(3):A24.

Benson C, Chirila C, Graham J, Radder C, Zheng Q, Muser E, Woodruff K. Health resource use and cost analysis of schizophrenia patients participating in a randomized, multicenter, double-blind, relapse prevention study of paliperidone palmitate 3-month formulation. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

François C, Danchenko N, Williams V, Nelson L, Williams NJ, Yarr S, DiBenedetti DB, Lançon C. Psychometric evaluation of the Depression and Family Functioning Scale (DFFS). Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

François C, Nielsen R, Danchenko N, Williams V, Lançon C. The effect of vortioxetine on family functioning in adults with major depressive disorder. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

Gascon M, Triguero-Mas M, Martinez D, Dadvand P, Forns J, Plasencia A, Nieuwenhuijsen MJ. Mental health benefits of long-term exposure to residential green and blue spaces: a systematic review. Int J Environ Res Public Health. 2015 Apr 22;12(4):4354-79. doi: 10.3390/ijerph120404354

Aguado J, Luciano JV, Cebolla A, Serrano-Blanco A, Soler J, García-Campayo J. Bifactor analysis and construct validity of the Five Facet Mindfulness Questionnaire (FFMQ) in non-clinical Spanish samples. Front Psychol. 2015 Apr 9;6:404. doi: 10.3389/fpsyg.2015.00404

Hong J, Novick D, Montgomery W, Aguado J, Dueñas H, Peng X, Haro JM. Should unexplained painful physical symptoms be considered within the spectrum of depressive symptoms? Clin Pract Epidemiol Ment Health. 2015 Mar 31;11:130-9. doi: 10.2174/1745017901511010130

Deal LS, Sleeper-Triplett J, DiBenedetti DB, Nelson L, McLeod L, Haydysch EE, Brown TM. Development and validation of the ADHD Benefits of Coaching Scale (ABCS). J Atten Disord. 2015 Mar;19(3):191-9. doi: 10.1177/1087054714558118

Zorrilla I, Aguado J, Haro JM, Barbeito S, López Zurbano S, Ortiz A, López P, Gonzalez-Pinto A. Cannabis and bipolar disorder: does quitting cannabis use during manic/mixed episode improve clinical/functional outcomes? Acta Psychiat Scand. 2015 Feb;131(2):100-10. doi: 10.1111/acps.12366

Amoly E, Dadvand P, Forns J, Lopez-Vicente M, Basagana X, Julvez J, Alvarez-Pedrerol M, Nieuwenhuijsen MJ, Sunyer J. Green and blue spaces and behavioral development in Barcelona schoolchildren: the BREATHE project. Environ Health Perspect. 2014 Dec;122(12):1351-8. doi: 10.1289/ehp.1408215

Whalley D, Luquiens A, Crawford SR, Laramée P, Doward LC, Price MA, Hawken N, Dorey J, Owens L, Llorca PM, Falissard B, Aubin HJ. The patient experience of alcohol use disorder. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam.

Whalley D, Crawford SR, Laramée P, Higuchi S, Hao W, Kim S-G, Luquiens A, Aubin HJ. Cultural adaptation of the alcohol quality of life scale for use in Japan, China, and Korea. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands.

Novick D, Montgomery W, Aguado J, Duenas H, Haro JM. Symptomatic factors in patients with major depressive disorder (MDD): results from an observational study. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands. [abstract] Value Health. 2014 Nov; 17(7):A543.

Novick D, Montgomery W, Treuer T, Aguado J, Kraemer S, Haro JM. Comparative effectiveness in terms of treatment discontinuation of orodispersable versus standard oral olanzapine tablets in non-adherent patients: results from a 1-year European outpatient observational study. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands. [abstract] Value Health. 2014 Nov; 17(7):A766.

Novick D, Montgomery W, Treuer T, Aguado J, Kraemer S, Haro JM. Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands. [abstract] Value Health. 2014 Nov; 17(7):A455.